NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer
June 30, 2022
We are very excited to announce that we have closed the two newest funds of the TCG fund family – The Column Group V (“TCG V”), a $615 million fund focused on early-stage investments, and The Column Group Opportunity III (“TCG Opportunity III”), also $615 million but focused on later stage investments in our companies. …
The Column Group Raises $1.23 Billion in Two New Funds Read More »